Amrize Ltd (AMRZ) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 3, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 10, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the AMRZ SEC filings page.
Amrize Ltd (AMRZ) reported $12.2B in revenue over the twelve months to Jun 30, 2026. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 3 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
AMRZ’s dominant mechanic is debt reduction alongside margin compression, while cash generation remains above accounting profit but capex absorbs more.
Cash conversion remained resilient in 2025: operating cash flow was$2.21B versus$1.19B of net income, even as earnings declined. Yet free cash flow fell to$1.42B while capital expenditures rose to$788M , making reinvestment burden—not weaker operating cash production—the main squeeze on distributable cash.
Operating leverage weakened: gross margin eased from
Debt dependence declined: debt-to-equity fell from 1.4x to 0.4x while liabilities declined, making the capital structure less leveraged. But the current ratio narrowed from 1.9x to 1.6x, so deleveraging did not translate into a larger short-term liquidity cushion.
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Amrize Ltd's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Amrize Ltd has an operating margin of 16.1%, meaning the company retains $16 of operating profit per $100 of revenue. This strong profitability earns a score of 86/100, reflecting efficient cost management and pricing power. This is down from 18.8% the prior year.
Amrize Ltd's revenue grew a modest 0.9% year-over-year to $11.8B. This slow but positive growth earns a score of 33/100.
Amrize Ltd has a moderate D/E ratio of 0.38. This balance of debt and equity financing earns a leverage score of 45/100.
Amrize Ltd's current ratio of 1.60 indicates adequate short-term liquidity, earning a score of 45/100. The company can meet its near-term obligations, though with limited headroom.
Amrize Ltd converts 12.0% of revenue into free cash flow ($1.4B). This strong cash generation earns a score of 73/100.
Amrize Ltd earns a strong 9.0% return on equity (ROE), meaning it generates $9 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 75/100. This is down from 12.8% the prior year.
Amrize Ltd scores 2.19, placing it in the grey zone between 1.81 and 2.99. The score is driven primarily by a large market capitalization ($24.1B) relative to total liabilities ($11.1B). This signals moderate financial risk that warrants monitoring.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Amrize Ltd passes 3 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 3 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.
For every $1 of reported earnings, Amrize Ltd generates $1.86 in operating cash flow ($2.2B OCF vs $1.2B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Amrize Ltd earns $8.82 in operating income for every $1 of interest expense ($1.9B vs $216.0M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.
Key Financial Metrics
Earnings & Revenue
Amrize Ltd generated $3.5B in revenue in Q2 2026. This represents an increase of 8.6% from the same quarter a year earlier. Against the prior quarter it is up 60.2%.
Amrize Ltd's EBITDA was $928.0M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 10.0% from the same quarter a year earlier. Against the prior quarter it is up 636.5%.
Amrize Ltd reported $478.0M in net income in Q2 2026. This represents an increase of 14.6% from the same quarter a year earlier. Against the prior quarter it is up 555.2%.
Amrize Ltd earned $0.86 per diluted share (EPS) in Q2 2026. This represents an increase of 14.7% from the same quarter a year earlier. Against the prior quarter it is up 552.6%.
Cash & Balance Sheet
Amrize Ltd generated $173.0M in free cash flow in Q2 2026, representing cash available after capex. This represents an increase of 1.2% from the same quarter a year earlier. Against the prior quarter it is up 114.8%.
Amrize Ltd held $729.0M in cash against $4.2B in long-term debt as of Q2 2026.
Amrize Ltd paid $0.11 per share in dividends in Q2 2026.
Margins & Returns
Amrize Ltd's gross margin was 28.4% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is down 0.8 percentage points from the same quarter a year earlier. Against the prior quarter it is up 18.9 percentage points.
Amrize Ltd's operating margin was 20.3% in Q2 2026, reflecting core business profitability. This is down 0.1 percentage points from the same quarter a year earlier. Against the prior quarter it is up 23.6 percentage points.
Amrize Ltd's net profit margin was 13.7% in Q2 2026, showing the share of revenue converted to profit. This is up 0.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 18.5 percentage points.
Amrize Ltd's ROE was 3.7% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 0.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 4.5 percentage points.
Capital Allocation
Amrize Ltd invested $245.0M in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 4.3% from the same quarter a year earlier. Against the prior quarter it is down 10.9%.
Not reported for Q2 2026.
Not reported for Q2 2026.
AMRZ Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.5B+8.6% | $2.2B+4.4% | $2.8B | $3.7B+6.6% | $3.2B-0.8% | $2.1B | N/A | $3.4B |
| Cost of Revenue | $2.5B+9.8% | $2.0B+6.5% | $2.1B | $2.6B+7.7% | $2.3B+0.6% | $1.9B | N/A | $2.4B |
| Gross Profit | $993.0M+5.5% | $208.0M-12.2% | $770.0M | $1.1B+4.2% | $941.0M-3.9% | $237.0M | N/A | $1.0B |
| SG&A Expenses | $283.0M-1.0% | $285.0M+17.3% | $287.0M | $312.0M+29.5% | $286.0M+25.4% | $243.0M | N/A | $241.0M |
| Operating Income | $711.0M+8.2% | -$72.0M-1340.0% | $476.0M | $778.0M-7.8% | $657.0M-12.9% | -$5.0M | N/A | $844.0M |
| EBITDA | $928.0M+10.0% | $126.0M-28.4% | $674.0M | $970.0M-6.1% | $844.0M-9.8% | $176.0M | N/A | $1.0B |
| Interest Expense | $78.0M+44.4% | $72.0M+554.5% | $72.0M | $79.0M+618.2% | $54.0M+440.0% | $11.0M | N/A | $11.0M |
| Income Tax | $146.0M+19.7% | -$41.0M-46.4% | $82.0M | $150.0M-3.2% | $122.0M-18.1% | -$28.0M | N/A | $155.0M |
| Net Income | $478.0M+14.6% | -$105.0M-11.7% | $317.0M | $545.0M-1.4% | $417.0M-12.0% | -$94.0M | N/A | $553.0M |
| EPS (Basic) | $0.87+16.0% | -$0.19-11.8% | $0.54+3.8% | $0.99-1.0% | $0.75-12.8% | -$0.17 | $0.52 | $1.00 |
| EPS (Diluted) | $0.86+14.7% | -$0.19-11.8% | $0.54+3.8% | $0.98-2.0% | $0.75-12.8% | -$0.17 | $0.52 | $1.00 |
| Diluted Shares (Avg) | 554M+0.1% | 553M0.0% | N/A | 554M+0.1% | 553M0.0% | 553M | N/A | 553M |
Not reported in any period shown, so not listed: R&D Expenses.
AMRZ Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $24.6B+3.5% | $24.3B | $24.2B+1.7% | $24.0B | $23.8B | N/A | $23.8B | N/A |
| Current Assets | $4.6B+6.0% | $4.3B | $4.6B-3.5% | $4.6B | $4.3B | N/A | $4.8B | N/A |
| Cash & Equivalents | $729.0M+21.3% | $1.1B+91.5% | $1.9B+21.3% | $826.0M+96.7% | $601.0M+66.9% | $574.0M | $1.6B | $420.0M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $1.6B-5.4% | $1.6B | $1.5B+2.6% | $1.5B | $1.6B | N/A | $1.5B | N/A |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill | $9.0B+0.2% | $9.1B | $9.0B+1.4% | $9.0B | $9.0B | N/A | $8.9B | N/A |
| Total Liabilities | $11.7B+3.5% | $11.2B | $11.1B-20.2% | $11.1B | $11.3B | N/A | $13.9B | N/A |
| Current Liabilities | $4.2B+32.2% | $3.1B | $2.9B+13.1% | $3.2B | $3.1B | N/A | $2.5B | N/A |
| Non-Current Liabilities | $7.6B-7.5% | $8.1B | $8.2B-27.7% | $8.0B | $8.2B | N/A | $11.3B | N/A |
| Long-Term Debt | $4.2B | $4.9B | $4.9B | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $12.9B+3.5% | $13.1B+36.3% | $13.1B+32.4% | $12.9B+31.1% | $12.4B+33.6% | $9.6B | $9.9B | $9.8B |
| Retained Earnings | $997.0M+1589.8% | $785.0M | $930.0M | $601.0M | $59.0M | N/A | $0 | N/A |
Not reported in any period shown, so not listed: Accounts Receivable.
AMRZ Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $418.0M+3.0% | -$893.0M-5.4% | $1.8B+4.5% | $845.0M+35.6% | $406.0M | -$847.0M | $1.7B | $623.0M |
| Depreciation & Amortization | $217.0M+16.0% | $198.0M+9.4% | $203.0M+4.6% | $192.0M+1.6% | $187.0M+2.7% | $181.0M | $194.0M | $189.0M |
| Stock-Based Compensation | N/A | $9.0M+800.0% | N/A | N/A | N/A | $1.0M | N/A | N/A |
| Capital Expenditures | $245.0M+4.3% | $275.0M+29.1% | $157.0M+86.9% | $183.0M-17.2% | $235.0M | $213.0M | $84.0M | $221.0M |
| Free Cash Flow | $173.0M+1.2% | -$1.2B-10.2% | $1.6B+0.2% | $662.0M+64.7% | $171.0M | -$1.1B | $1.6B | $402.0M |
| Investing Cash Flow | -$234.0M-558.8% | -$662.0M-967.7% | -$150.0M+57.4% | -$200.0M+52.9% | $51.0M | -$62.0M | -$352.0M | -$425.0M |
| Financing Cash Flow | -$555.0M-20.1% | $743.0M+814.4% | -$577.0M-254.0% | -$412.0M-188.1% | -$462.0M | -$104.0M | -$163.0M | -$143.0M |
| Dividends Paid | $305.0M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Not reported in any period shown, so not listed: Share Buybacks.
AMRZ Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 28.4%-0.8pp | 9.5%-1.8pp | 27.2% | 29.5%-0.7pp | 29.2%-1.0pp | 11.3% | N/A | 30.2% |
| Operating Margin | 20.3%-0.1pp | -3.3%-3.1pp | 16.8% | 21.2%-3.3pp | 20.4%-2.8pp | -0.2% | N/A | 24.5% |
| Net Margin | 13.7%+0.7pp | -4.8%-0.3pp | 11.2% | 14.8%-1.2pp | 13.0%-1.7pp | -4.5% | N/A | 16.1% |
| Return on Equity | 3.7%+0.4pp | -0.8%+0.2pp | 2.4% | 4.2%-1.4pp | 3.4%-1.7pp | -1.0% | N/A | 5.6% |
| Return on Assets | 1.9%+0.2pp | -0.4% | 1.3% | 2.3% | 1.8% | N/A | N/A | N/A |
| Current Ratio | 1.10-0.3x | 1.40 | 1.60-0.3x | 1.45 | 1.38 | N/A | 1.87 | N/A |
| Debt-to-Equity | 0.33-0.6x | 0.38 | 0.38-1.0x | 0.86 | 0.91 | N/A | 1.40 | N/A |
| Asset Turnover | 0.140.0x | 0.09 | 0.12 | 0.15 | 0.14 | N/A | N/A | N/A |
| FCF Margin | 5.0%-0.4pp | -53.5%-2.8pp | 58.1% | 18.0%+6.3pp | 5.3% | -50.7% | N/A | 11.7% |
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Amrize Ltd AMRZ | FY2025 | $11.8B | $1.2B | 10.0% | $24.1B | 60/100 |
| Martin Mari Mat MLM | FY2025 | $6.2B | $1.1B | 18.5% | $35.9B | 65/100 |
| Vulcan Matrls VMC | FY2025 | $7.9B | $1.1B | 13.6% | $33.7B | 62/100 |
| Crh Plc CRH | FY2025 | $37.4B | $3.8B | 10.0% | $60.7B | 58/100 |
| Cemex SAB de CV CX | FY2025 | $16.1B | $970.0M | 6.0% | $15.1B | 29/100 |
| James Hardie JHX | FY2026 | $4.8B | $104.0M | 2.1% | $16.6B | 54/100 |
Where Amrize Ltd Ranks
Frequently Asked Questions
What is Amrize Ltd's annual revenue?
Amrize Ltd (AMRZ) reported $11.8B in total revenue for fiscal year 2025. This represents a 0.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Amrize Ltd's revenue growing?
Amrize Ltd (AMRZ) revenue grew by 0.9% year-over-year, from $11.7B to $11.8B in fiscal year 2025.
Is Amrize Ltd profitable?
Yes, Amrize Ltd (AMRZ) reported a net income of $1.2B in fiscal year 2025, with a net profit margin of 10.0%.
What is Amrize Ltd's EBITDA?
Amrize Ltd (AMRZ) had EBITDA of $2.7B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Amrize Ltd have?
As of fiscal year 2025, Amrize Ltd (AMRZ) had $1.9B in cash and equivalents against $4.9B in long-term debt.
What is Amrize Ltd's gross margin?
Amrize Ltd (AMRZ) had a gross margin of 25.7% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Amrize Ltd's operating margin?
Amrize Ltd (AMRZ) had an operating margin of 16.1% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Amrize Ltd's net profit margin?
Amrize Ltd (AMRZ) had a net profit margin of 10.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Amrize Ltd's return on equity (ROE)?
Amrize Ltd (AMRZ) has a return on equity of 9.0% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Amrize Ltd's free cash flow?
Amrize Ltd (AMRZ) generated $1.4B in free cash flow during fiscal year 2025. This represents a -13.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Amrize Ltd's operating cash flow?
Amrize Ltd (AMRZ) generated $2.2B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Amrize Ltd's total assets?
Amrize Ltd (AMRZ) had $24.2B in total assets as of fiscal year 2025, including both current and long-term assets.
What are Amrize Ltd's capital expenditures?
Amrize Ltd (AMRZ) invested $788.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is Amrize Ltd's current ratio?
Amrize Ltd (AMRZ) had a current ratio of 1.60 as of fiscal year 2025, which is generally considered healthy.
What is Amrize Ltd's debt-to-equity ratio?
Amrize Ltd (AMRZ) had a debt-to-equity ratio of 0.38 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Amrize Ltd's return on assets (ROA)?
Amrize Ltd (AMRZ) had a return on assets of 4.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Amrize Ltd's P/E ratio?
Amrize Ltd (AMRZ) trades at 19.5x earnings, its market capitalization divided by net income of $1.2B net income, trailing 12 months to June 30, 2026. The market capitalization is $24.1B as of Sep 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Amrize Ltd's price-to-sales ratio?
Amrize Ltd (AMRZ) trades at 2.0x sales, its market capitalization divided by revenue of $12.2B revenue, trailing 12 months to June 30, 2026. The market capitalization is $24.1B as of Sep 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Amrize Ltd's Altman Z-Score?
Amrize Ltd (AMRZ) has an Altman Z-Score of 2.19, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Amrize Ltd's Piotroski F-Score?
Amrize Ltd (AMRZ) has a Piotroski F-Score of 3 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Amrize Ltd's earnings high quality?
Amrize Ltd (AMRZ) has an earnings quality ratio of 1.86x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Amrize Ltd cover its interest payments?
Amrize Ltd (AMRZ) has an interest coverage ratio of 8.82x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Amrize Ltd?
Amrize Ltd (AMRZ) scores 60 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.